Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SMS PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 19.80103.90-50.38-3.8346.34

What is the latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS is 19.80 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202519.80
Mar2024103.90
Mar2023-50.38
Mar2022-3.83
Mar202146.34

How is Core EBITDA Growth of SMS PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 19.8
-80.94
Mar2024 103.9
Positive
Mar2023 -50.38
Negative
Mar2022 -3.83
Negative
Mar2021 46.34 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹3,949.9 Cr 11% 14.7% 71.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 0.5% 4.6% 11.7% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr -0.6% 2.2% -0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 3.2% 8.1% 43.9% Stock Analytics
CIPLA ₹117,820.0 Cr 1.1% 5.6% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.3% 5.6% -0.1% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

11%

14.7%

71.3%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses